|
| |
| | Superficial Bladder Cancer Therapy |
 | | Bladder cancer is the fourth most common cancer among men and the eighth most common cancer among women. | | | Ratliff, T.L., Kavoussi, L.R., Catalona, W.J.: Role of fibronetin in intravesical BCG therapy for superficial bladder cancer. | | | To use immunotherapy effectively in the management of bladder cancer or other malignancy, it is important to consider basic principles and understand the differences between immunotherapy and chemotherapy. |
|
http://www.duj.com/Article/Schenkman.html
(6457 words)
|
|
| |
| | Cancer Control Journal: Systemic Therapy for Invasive Bladder Cancer |
| | For example, Shipley has expressed the view that the Canadian NCIC study has established the role of chemoradiation in achieving local control and that this should be incorporated into other randomized trials to assess innovations in neoadjuvant or adjuvant systemic therapy (personal communication, 1996). | | | Methods: The authors review the literature on systemic treatment for both localized and metastatic bladder cancer, and they include their experience in defining approaches to various stages of disease. | | | More recently, Skinner and colleagues[27] conducted a randomized trial for patients with deeply invasive bladder cancer that was staged at cystectomy. |
|
http://www.moffitt.usf.edu/pubs/ccj/v3n6/a2.html
(2364 words)
|
|
| |
| | eMedicine - Bladder Cancer : Article by Gary David Steinberg, MD |
| | Warde P, Gospodarowicz MK: New approaches in the use of radiation therapy in the treatment of infiltrative transitional-cell cancer of the bladder. | | | BCG immunotherapy is the most effective intravesical therapy and involves a live attenuated strain of Mycobacterium bovis. | | | Neoadjuvant external beam radiation therapy has been attempted for muscle-invasive bladder cancer with no improvement in survival rate. |
|
http://www.emedicine.com/med/topic2344.htm
(5721 words)
|
|
| |
| | Carcinoma in Situ of the Penis in a 76-Year-Old Circumcised Man |
| | In one study of 11 men with carcinoma in situ of the penis, 10 had been circumcised as infants. | | | The authors wish to express their gratitude to Ann C. Smith, MD, for referral of this patient. | | | Lakeland Center, 9601 Townline Rd. Minocqua, WI 54548. |
|
http://www.cirp.org/library/disease/cancer/vanhowe
(1914 words)
|
|
| |
| | Bladder Cancer - Patient UK |
| | Aims to relieve, assist and help persons who have undergone, or are about to undergo urological surgery for urinary diversion and to improve their quality of life and of those who care for them. | | | An extremely comprehensive and well-resourced site with a wealth of information on cancers including bladder cancer and links to a wide range of other sources of information. | | | CancerBACUP aims to help people live with cancer by providing information and emotional support for patients, their families and health professionals. |
|
http://www.patient.co.uk/illness/b/bladder_cancer.html
(274 words)
|
|
| |
| | Bladder Cancer |
| | The utility of this multimodality approach was confirmed in a prospective, randomized comparison of radiation therapy and chemoradiation therapy, which reported an improved rate of local control when cisplatin was given in conjunction with radiation therapy, even though there was no improvement in the rate of distant metastases or overall survival. | | | Goffinet DR, Schneider MJ, Glatstein EJ, et al.: Bladder cancer: results of radiation therapy in 384 patients. | | | Pollera CF, Ceribelli A, Crecco M, et al.: Weekly gemcitabine in advanced bladder cancer: a preliminary report from a phase I study. |
|
http://imsdd.meb.uni-bonn.de/cancernet/101206.html
(8464 words)
|
|
| |
| | Tumors blad5001 |
| | Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case-control studies. | | | Uncertainty, stage and outcome of invasive bladder cancer. | | | Recurrence (does it come back), recurrence rate (how soon/often does it come back), progression and (disease specific) survival are of importance. |
|
http://www.infobiogen.fr/services/chromcancer/Tumors/blad5001.html
(3856 words)
|
|
| |
| | Superficial Bladder Cancer |
| | Long-term follow-up is, of course, necessary but it need not be aggressive, especially after the first 2 years. | | | Emmanuel Schenkman, M.D. and Donald L. Lamm, M.D. Superficial bladder cancer: Progression and recurrence. | | | http://www.duj.com/Article/Schenkman.html Superficial Bladder Cancer Therapy References as reviewed by Drs. |
|
http://blcwebcafe.org/superficialblca.asp
(2960 words)
|
|
| |
| | Bladder Cancer, CancerLinksUSA.com |
| | This is a response to a question about BCG treatment for bladder cancer by J.H. Chang, M.D. from Oncolink. | | | Learn the staging system from the explanation from the National Cancer Institute. | | | We subscribe to the HONcode principles of the Health On the Net Foundation |
|
http://www.cancerlinksusa.com/bladder/home.html
(406 words)
|
|
| |
| | Bladder Cancer |
| | This is the most advanced stage of bladder cancer. | | | The patient can void through the urethra in the same way as before surgery. | | | Unfortunately, metastatic bladder cancer may also be present the very first time a patient has any symptoms from bladder cancer. |
|
http://www.med.wayne.edu/urology/DISEASES/bladdercancer.html
(1430 words)
|
|
| |
| | AllRefer Health - Bladder Cancer (Transitional Cell Carcinoma of the Bladder) |
| | Women who received radiation therapy for the treatment of cervical cancer have an increased risk of developing transitional cell bladder cancer, as do some people who received the chemotherapy drug, cyclophosphamide (Cytoxan). | | | This risk, however, does show a gradual decline in individuals who quit smoking. | | | You are here : AllRefer.com > Health > Diseases and Conditions > Bladder Cancer |
|
http://health.allrefer.com/health/bladder-cancer-info.html
(696 words)
|
|
| |
| | [Systemic adjuvant chemotherapy of bladder carcinoma with 5 fluorouracil and cyclophosphamide]. |
| | Patients with bladder cancer in pT2 and pT3 infiltrating stages have a 5 year survival rate less than 50% after primary surgical and/or radiant therapy. | | | Our experience has not shown therefore any improvement compared with primary treatment alone. | | | For this purpose, 16 patients underwent treatment with 5-Fluorouracil and cyclophosphamide (min. |
|
http://www.pdg.cnb.uam.es/UniPub/iHOP/gp/6933962.html
(102 words)
|
|
| |
| | Sloan-Kettering - Bladder Cancer |
| | In this section you can find information about our expertise in treating patients with bladder cancer, our services, and our research. | | | Memorial Sloan-Kettering physicians treat more bladder cancer patients each year than are treated at any other cancer center in the nation. | | | The treatment for bladder cancer varies depending on the stage of disease at the time of diagnosis. |
|
http://www.mskcc.org/document/WICBLAD.htm
(261 words)
|
|
| |
| | MedlinePlus: Enzyme measure helps detect bladder cancer |
| | Scientists said established approaches for detecting bladder cancer are either invasive or costly, or have limited sensitivity, highlighting the need for the development of a non-invasive, reliable test. | | | At present, about 20 percent of patients die each year, but when the disease is diagnosed and treated in its early stage, the chances of survival are good. | | | The incidence of human bladder cancer has greatly increased, with more than 60,000 new cases diagnosed annually in just the United States, and now represents the 4th most common malignancy in men and the 10th most common in women. |
|
http://www.nlm.nih.gov/medlineplus/news/fullstory_27672.html
(212 words)
|
|
| |
| | Helping Patients Make Informed Treatment Choices |
| | Most Popular Guides: Atrial Fibrillation Bipolar Disorder Chronic Lymphocytic Leukemia Peripheral Neuropathy Ductal Carcinoma in Situ | | | Where can you locate doctors, researchers, hospitals and medical centers with specialized interest and expertise in the disease? |
|
http://www.medifocus.com
(209 words)
|
|
| |
| | cancer |
| | Most patients undergoing this form of diversion psychologically adjust to the change in body image with time. | | | Among patients with invasive bladder cancer, treatment must be individualized accounting for general medical condition, extent of cancer, and personal preferences.10 Once it has been decided that more aggressive therapy is needed in the way of external beam irradiation, systemic chemotherapy, surgery or any combination thereof, the safety of bladder preservation should be considered. | | | Recently, the combination of radiation therapy and intravenous chemotherapy (which sensitizes the cancer to irradiation) has given a glimmer of hope.12 58% of patients treated with platinum-based combination chemotherapy and irradiation were able to preserve their bladders while remaining free of disease at 4 years. |
|
http://www.cancernews.com/bladder5.htm
(660 words)
|
|
| |
| | Biologictherapy.Org: Bladder Cancer: Clinical Presentation of Bladder Carcinoma |
| | However, despite its very high specificity (>95%), the poor overall sensitivity (less than 40%) and subjective interpretation mean a negative cytology is never sufficient to rule out bladder cancer. | | | Urinary cytology is a useful adjunct especially in diagnosing patients with CIS that may even be difficult to visualize cystoscopically. | | | The vast majority of patients with bladder cancer present with gross painless hematuria that is usually transient in nature and too commonly ignored by the patient and often misattributed to urinary tract infections, gynecological disease, BPH, strenuous exertion/exercise, or anti-coagulant use by physicians. |
|
http://www.biologictherapy.org/bladdercancer/bladder_clinical.html
(332 words)
|
|
| |
| | Bladder Cancer Review |
| | The choice of treatment for you or your loved one depends on the stage of the disease, the presence of frailty or other medical conditions (given that bladder cancer more commonly affects older people), how aggressive the disease seems to be and the person's preferences. | | | You will also learn about the doctors, hospitals, and medical centers that are at the leading edge in conducting clinical research about Bladder Cancer. | | | Bladder cancer's staging, treatment and prognosis depends on how deeply it has invaded the organ. |
|
http://www.cancergroup.com/em5.html
(387 words)
|
|
| |
| | News - False-Positive Urine Test Results For Bladder Carcinoma Do Not Predict Recurrence Or Progression Rates |
| | Of these patients, 51 had a history of bladder cancer, and 10 underwent transurethral resection for the suspicion of bladder cancer but had negative pathological findings. | | | False-positive findings on non-invasive urine tests for bladder carcinoma do not predict recurrence of progression rates in patients with a history of bladder cancer or who had negative pathological findings following transurethral resection. | | | Adenocarcinoma in Bladder Diverticulum, Metastatic from Gastric Cancer |
|
http://www.docguide.com/news/content.nsf/news/8525697700573E1885256CC5005CFDCB
(534 words)
|
|
| |
| | Renal Pathology |
| | Urothelial carcinoma is often multifocal and has a tendency to recur. | | | This bladder was removed surgically from a male who had a long history of smoking. | | | Urothelial carcinoma can arise anywhere in the urothelium lining the urinary tract from the urethra to the calyces, but is most common in bladder. |
|
http://www-medlib.med.utah.edu/WebPath/RENAHTML/BLAD060.html
(84 words)
|
|
| |
| | Bladder carcinoma |
| | Schistosoma haematobium associated with increased risk of squamous carcinoma | | | 20% of transitional cell carcinomas are believed to result from occupational factors | | | Requires bladder muscle to be included in specimen |
|
http://www.surgical-tutor.org.uk/system/urinary/tcc.htm
(192 words)
|
|
| |
| | IngentaConnect Methylation of a CpG Island within the Uroplakin Ib Promoter: A P... |
| | The data are consistent with the hypothesis that methylation of specific sites within the uroplakin Ib promoter may be an important factor in the loss of uroplakin Ib expression in TCCs. | | | Expression of uroplakin Ib mRNA is reduced or absent in many transitional cell carcinomas (TCCs) but molecular mechanisms underlying loss of expression remain to be determined. | | | In particular, loss of uroplakin Ib expression correlated with methylation of a putative Sp1/NF B binding motif. |
|
http://www.ingentaconnect.com/content/neo/neo/2004/00000006/00000002/art00004
(257 words)
|
|
| |
| | Value of a panel of antibodies to identify the primary origin of adenocarcinomas presenting as bladder carcinoma. |
| | In the present study we tried to differentiate primary urinary bladder adenocarcinomas from adenocarcinomas arising from the surrounding organs, based on their antigen profiles in routinely processed, paraffin-embedded tissue specimens. | | | AIMS: Adenocarcinomas may arise primarily from the urinary bladder, but secondary involvement from adenocarcinomas arising in adjacent organs is more common. | | | CONCLUSIONS: For the surgical pathologist, a panel of antibodies consisting of CEA, PSA, OC125 and vimentin is helpful to differentiate primary urinary bladder adenocarcinomas from adenocarcinomas originating from prostate and endometrium, less helpful in differentiation with urachal carcinoma, and not helpful in differentiation with colonic, cervical and ovarian carcinoma. |
|
http://www.pdg.cnb.uam.es/UniPub/iHOP/gp/1406534.html
(253 words)
|
|
| |
| | Establishment of two new human bladder carcinoma cell lines, CAL 29 and CAL 185. Comparative study of cell scattering ... |
| | In conclusion, these two new cell lines could be good models to dissect the molecular mechanisms involved in invasion and metastasis development in human bladder cancer. | | | We describe here two new human urothelial carcinoma cell lines, CAL 29 and CAL 185, established from two patients with high-grade tumours and which display very different properties in vitro. | | | These agents could help to understand the intracellular pathways involved in invasiveness and to find new targets for limiting metastasis. |
|
http://www.nature.com/bjc/journal/v85/n9/abs/6692105a.html
(285 words)
|
|
| |
| | U.S. Pregrant 20040248096 - Detecting recurrence and high stage bladder carcinoma |
| | The use of such prognostic marker for the prediction of bladder tumor recurrence and high stages facilitates more effective management of the cancer. | | | Analysis of nucleophosmin/B23 mRNA expression provides sensitive, quantitative, rapid and specific analysis to detect cancer cells in tissues for predicting and monitoring recurrence and high stage bladder carcinoma. | | | Over-expression of nucleophosmin/B23 mRNA is a useful prognostic marker for disease recurrence and high stages in bladder carcinoma. |
|
http://cxp.paterra.com/uspregrant20040248096.html
(231 words)
|
|
| |
| | Urinary Bladder Carcinoma |
| | Tumor extension to the organs attached to the bladder (radical cystoprostatectomies, radical cystectomies, anterior extenterations): | | | Surgical margins (uretral margin, urethral margin, perivesicular soft tissue margin, bladder mucosal margin***): | | | Seminal vesicles (any spread of carcinoma either through epithelium or by direct extension of infiltrative tumor): |
|
http://www.peacefulpackers.com/informatics/m01_62.htm
(243 words)
|
|
|
